Entry Detail



General Information

Database ID:exR0766527
RNA Name:MAPKAPK5-AS1
RNA Type:lncRNA
Chromosome:chr12
Starnd:-
Coordinate:
Start Site(bp):111839764End Site(bp):111842902
External Links:ENSG00000234608



Disease Information

Disease Name:Lung Cancer
Disease Category:Cancers
MeSH ID:D008175
Type:Neoplasms/Respiratory Tract Neoplasms
Alias:Lung Neoplasms//Pulmonary Neoplasms//Neoplasms, Lung//Lung Neoplasm//Neoplasm, Lung//Neoplasms, Pulmonary//Neoplasm, Pulmonary//Pulmonary Neoplasm//Lung Cancer//Cancer, Lung//Cancers, Lung//Lung Cancers//Pulmonary Cancer//Cancer, Pulmonary//Cancers, Pulmonary//Pulmonary Cancers//Cancer of the Lung//Cancer of Lung



Expression Detail

GEO ID:GSE69732
Description:Circulating RNAs profile in non-small cell lung cancer patients
Experimental Design:Cancer vs Control
Case Disease Type:Lung Cancer
Case Disease SubType:Non-Small Cell Lung Cancer
Case Sample:Non-Small Cell Lung Cancer
Control Sample:Healthy
Number of Case:3
Number of Control:3
Number of Samples:6





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABRACL
chr6
139028745
139043302
+
AFF1
chr4
86935002
87141054
+
ABCE1
chr4
145098288
145129524
+
ABLIM1
chr10
114431113
114768061
-
AKIRIN1
chr1
38991276
39006059
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-96-5p
chr7
129774739
129774761
-
hsa-miR-325
chrX
77005464
77005486
-
hsa-miR-1271-5p
chr5
176367960
176367981
+
circRNA targets:NA
lncRNA targets:NA
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:26417025
Title:Circulating Messenger RNA Profiling with Microarray and Next-generation Sequencing: Cross-platform Comparison.
Author:Shih CL, Luo JD, Chang JW, Chen TL, Chien YT, Yu CJ, Chiou CC.
Journal:Cancer Genomics Proteomics. 2015 Sep-Oct;12(5):223-30.
Description:Genes with higher expression levels have cross-platform concordance and can be potential biomarkers.